EP3896158A4 - Method for inducing deletion in genomic dna - Google Patents
Method for inducing deletion in genomic dna Download PDFInfo
- Publication number
- EP3896158A4 EP3896158A4 EP19896405.8A EP19896405A EP3896158A4 EP 3896158 A4 EP3896158 A4 EP 3896158A4 EP 19896405 A EP19896405 A EP 19896405A EP 3896158 A4 EP3896158 A4 EP 3896158A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- genomic dna
- inducing deletion
- deletion
- inducing
- genomic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012217 deletion Methods 0.000 title 1
- 230000037430 deletion Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018231649 | 2018-12-11 | ||
US201962938346P | 2019-11-21 | 2019-11-21 | |
PCT/JP2019/048426 WO2020122104A1 (en) | 2018-12-11 | 2019-12-11 | Method for inducing deletion in genomic dna |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3896158A1 EP3896158A1 (en) | 2021-10-20 |
EP3896158A4 true EP3896158A4 (en) | 2022-11-02 |
Family
ID=71077370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19896405.8A Pending EP3896158A4 (en) | 2018-12-11 | 2019-12-11 | Method for inducing deletion in genomic dna |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220017888A1 (en) |
EP (1) | EP3896158A4 (en) |
JP (1) | JP7395159B2 (en) |
WO (1) | WO2020122104A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024204287A1 (en) * | 2023-03-27 | 2024-10-03 | 国立大学法人京都大学 | Crrna having modified nucleotide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017066497A2 (en) * | 2015-10-13 | 2017-04-20 | Duke University | Genome engineering with type i crispr systems in eukaryotic cells |
WO2019246555A1 (en) * | 2018-06-21 | 2019-12-26 | Cornell University | Type i crispr system as a tool for genome editing |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA45491A (en) * | 2016-06-27 | 2019-05-01 | Juno Therapeutics Inc | CMH-E RESTRICTED EPITOPES, BINDING MOLECULES AND RELATED METHODS AND USES |
WO2018098480A1 (en) * | 2016-11-28 | 2018-05-31 | The Board Of Regents Of The University Of Texas System | Prevention of muscular dystrophy by crispr/cpf1-mediated gene editing |
JOP20190166A1 (en) * | 2017-01-05 | 2019-07-02 | Univ Texas | Optimized strategy for exon skipping modifications using crispr/cas9 with triple guide sequences |
WO2018175733A1 (en) * | 2017-03-22 | 2018-09-27 | Novartis Ag | Biomarkers and car t cell therapies with enhanced efficacy |
WO2018179578A1 (en) | 2017-03-30 | 2018-10-04 | 国立大学法人京都大学 | Method for inducing exon skipping by genome editing |
JOP20190257A1 (en) * | 2017-04-28 | 2019-10-28 | Novartis Ag | 6-6 fused bicyclic heteroaryl compounds and their use as lats inhibitors |
WO2018204493A1 (en) * | 2017-05-04 | 2018-11-08 | The Trustees Of The University Of Pennsylvania | Compositions and methods for gene editing in t cells using crispr/cpf1 |
US11866697B2 (en) * | 2017-05-18 | 2024-01-09 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
ES2980050T3 (en) * | 2017-06-08 | 2024-09-27 | Osaka Univ | Method for manufacturing DNA-edited eukaryotic cells |
EP3674404A4 (en) * | 2017-08-21 | 2021-05-26 | Tokushima University | Target sequence specific alteration technology using nucleotide target recognition |
-
2019
- 2019-12-11 WO PCT/JP2019/048426 patent/WO2020122104A1/en unknown
- 2019-12-11 US US17/309,607 patent/US20220017888A1/en active Pending
- 2019-12-11 JP JP2020559274A patent/JP7395159B2/en active Active
- 2019-12-11 EP EP19896405.8A patent/EP3896158A4/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017066497A2 (en) * | 2015-10-13 | 2017-04-20 | Duke University | Genome engineering with type i crispr systems in eukaryotic cells |
WO2019246555A1 (en) * | 2018-06-21 | 2019-12-26 | Cornell University | Type i crispr system as a tool for genome editing |
Non-Patent Citations (2)
Title |
---|
CSÖRGO BÁLINT ET AL: "A compact Cascade-Cas3 system for targeted genome engineering", NATURE METHODS, vol. 17, no. 12, 1 December 2020 (2020-12-01), pages 1183 - 1190, XP037307380, ISSN: 1548-7091, DOI: 10.1038/S41592-020-00980-W * |
See also references of WO2020122104A1 * |
Also Published As
Publication number | Publication date |
---|---|
US20220017888A1 (en) | 2022-01-20 |
JP7395159B2 (en) | 2023-12-11 |
JPWO2020122104A1 (en) | 2021-10-21 |
EP3896158A1 (en) | 2021-10-20 |
WO2020122104A1 (en) | 2020-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3487992A4 (en) | Methods and compositions for modifying genomic dna | |
EP3542296A4 (en) | Methods and systems for predicting dna accessibility in the pan-cancer genome | |
EP3382018A4 (en) | Dna methylation editing kit and dna methylation editing method | |
EP3271021A4 (en) | Tat-induced crispr/endonuclease-based gene editing | |
EP3323890A4 (en) | Method for inducing site-specific rna mutations, target editing guide rna used in method, and target rna target editing guide rna complex | |
EP3132025A4 (en) | Methods and compositions for modifying genomic dna | |
EP3292219A4 (en) | Methods and kits for fragmenting dna | |
EP3611258A4 (en) | System and method for genome editing | |
EP3444334A4 (en) | Method for inducing cd8+ t cells | |
EP3332034A4 (en) | Systems and methods for genomic analysis | |
EP3186375A4 (en) | Novel cas9 proteins and guiding features for dna targeting and genome editing | |
EP3155116A4 (en) | Method for gene editing | |
EP3164510A4 (en) | Method, substrate and device for separating nucleic acids | |
EP3450569A4 (en) | Dna amplification method | |
EP3604524A4 (en) | New technique for genomic large fragment direct cloning and dna multi-molecular assembly | |
EP3565563A4 (en) | Nucleic acids and methods for genome editing | |
EP3826021A4 (en) | Method for preserving and using genome and genomic data | |
EP3276184A4 (en) | Shovel and method for driving shovel | |
IL280203A (en) | Method for editing dna in cell-free system | |
EP3546575A4 (en) | Genome editing method | |
WO2017107898A9 (en) | Compositions and methods for gene editing | |
EP3239288A4 (en) | Pcr apparatus comprising repeated sliding means, and pcr method using same | |
EP3733842A4 (en) | System and method for genome editing | |
EP3508587A4 (en) | Dna sequencing method | |
EP3564391A4 (en) | Method, device and kit for detecting fetal genetic mutation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210611 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20221004 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07K 14/705 20060101ALI20220927BHEP Ipc: C12N 5/10 20060101ALI20220927BHEP Ipc: C12N 15/09 20060101AFI20220927BHEP |